{
  "cik": 1699031,
  "cik_padded": "0001699031",
  "entityName": "GRAIL, Inc.",
  "fiscal_years": [
    {
      "accn": "0001628280-26-017319",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 909000.0,
        "cash": 249727000.0,
        "eps_diluted": -11.11,
        "free_cash_flow": -299916000.0,
        "net_income": -408351000.0,
        "operating_cash_flow": -299007000.0,
        "operating_income": -562163000.0,
        "revenue": 147172000.0,
        "stockholders_equity": 2577862000.0,
        "total_assets": 2922015000.0,
        "total_liabilities": 344153000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1335032674363484,
        "revenue_growth_yoy": 0.17179824037581115,
        "roa_avg2y": -0.13829931712445148,
        "roa_period_end": -0.13974979594560602,
        "roe_avg2y": -0.16072802314855725,
        "roe_period_end": -0.15840685032790738
      }
    },
    {
      "accn": "0001628280-26-017319",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5208000.0,
        "cash": 214234000.0,
        "eps_diluted": -63.54,
        "free_cash_flow": -582364000.0,
        "net_income": -2027005000.0,
        "operating_cash_flow": -577156000.0,
        "operating_income": -2189158000.0,
        "revenue": 125595000.0,
        "stockholders_equity": 2503405000.0,
        "total_assets": 2983307000.0,
        "total_liabilities": 479902000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.19169970500178757,
        "revenue_growth_yoy": 0.3489608506524891,
        "roa_avg2y": -0.5877829314579228,
        "roa_period_end": -0.6794490141309627,
        "roe_period_end": -0.8096991897036235
      }
    },
    {
      "accn": "0001628280-26-017319",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12887000.0,
        "cash": 97287000.0,
        "eps_diluted": -47.21,
        "free_cash_flow": -608687000.0,
        "net_income": -1465685000.0,
        "operating_cash_flow": -595800000.0,
        "operating_income": -1515382000.0,
        "revenue": 93105000.0,
        "total_assets": 3913814000.0,
        "total_liabilities": 267627000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.37449020316243953
      }
    }
  ],
  "latest_filing": {
    "accn": "0001628280-26-017319",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "8071",
  "sic_description": "Services-Medical Laboratories",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001699031.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001699031.json"
  },
  "ticker": "GRAL"
}